Deutsche Bank
BDRX

Deutsche Bank’s Biodexa Pharmaceuticals BDRX Stock Holding History

Deutsche Bank’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Hold
0
– -$76K – 4536
2020
Q4 		– Hold
0
– – – 3989
2020
Q1 		– Hold
0
– -$6K – 4355
2019
Q4 		– Hold
0
– – – 4612
2019
Q3 		– Hold
0
– – – 4883
2019
Q2 		– Hold
0
– – – 5283
2019
Q1 		– Hold
0
– – – 4156
2018
Q4 		– Hold
0
– – – 5091
2018
Q2 		– Hold
0
– – – 5407
2018
Q1 		– Hold
0
– – – 5391
2016
Q3 		– Hold
0
– – – 4909
2016
Q2 		– Hold
0
– – – 5171
2016
Q1 		– Hold
0
– – – 5151
2015
Q4 		– Hold
0
– – – 5266

Other funds holding BDRX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return